证券代码：002028 证券简称：思源电气 公告编号：2025-027 思源电气股份有限公司 关于调整 2023 年股票期权激励计划 、《关于提请股东大会授权董事会办理股权激励相关事宜的决议》， 公司第七届监事会第二十次会议审议通过上述议案并发表同意的意见，公司独立董事发表了 独立意见。北京大成（上海）律师事务所出具了法律意见书。 期权激励计划激励对象名单的公示》 ，对本次拟授予激励对象进行了公示。2023 年 6 月 6 日， 公司监事会发表了《监事会关于公司 2023 年股票期权激励计划激励对象名单的公示情况及 核查意见的说明》 激励计划（草案）>及其摘要的议案》、 《关于公司<2023 年股票期权激励计划实施考核管理 办法>的议案》、 激励对象、期权数量、行权价格及注销部分期权的公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚 假记载、误导性陈述或重大遗漏。无董事不能保证公告内容真实、准确、完整。 思源电气股份有限公司（下称"公司"）第八届董事会第二十一次会议审议通过了《关 于调整 2023 年股票期权激励计划激励对象、期权数量、行权价格及注销部分期权的决议》， 具体情况如下： 一 ...

证券代码：600654 证券简称：中安科 公告编号：2025-055 中安科股份有限公司 关于 2023 年股票期权与限制性股票激励计划预留授予 （一）本次激励计划相关审批程序 于 <公司 ensp="ensp" 年股票期权与限制性股票激励计划="年股票期权与限制性股票激励计划" 草案="草 案"> 及其摘要的议案》《关 于 <公司 ensp="ensp" 年股票期权与限制性股票激励计划实施考核管理办法="年股票期权与限制性股票 激励计划实施考核管理办法"> 的议案》《关 于提请股东大会授权董事会办理公司股权激励计划有关事项的议案》，公司独立董 事对上述议案发表了明确同意的独立意见，律师出具了相应的法律意见书。 同日，公司召开了第十一届监事会第五次会议审议通过了《关于 <公司 ensp="ensp"> 年股票期权与限制性股票激励计划（草案）>及其摘要的议案》《关于 <公司 ensp="ensp"> 年股票期权与限制性股票激励计划实施考核管理办法>的议案》。 收到任何异议。2023 年 3 月 28 日，公司公告了《中安科股份有限公司监事会关于 对 2023 年股票期权与限制性股票激励计划首次授予对象名单审核意 ...

一、本激励计划已履行的决策程序 年限制性股票激励计划（草案）>及其摘要的议案》 证券代码：002516 证券简称：旷达科技 公告编号：2025-022 旷达科技集团股份有限公司关于 提示性公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整， 没有虚假记载、误导性陈述或重大遗漏。 特别提示： 划》（以下简称"本激励计划"）第一个解除限售期解除限售条件已经成就，本次符合 解除限售条件的激励对象共计7名，可解除限售的限制性股票数量为524.00万股，占 公司当前总股本的0.3563%。 《关于 <公司2024年限制性股票激励> 计划实施考核管理办法>的议案》及《关于提请股东大会授权董事会办理股权激励相关 事宜的议案》，独立财务顾问及律师出具了相应的报告和法律意见书。 年限制性股票激励计划（草案）>及其摘要的议案》 《关于 <公司2024年限制性股票激励> 计划实施考核管理办法>的议案》及《关于核实 <公司2024年限制性股票激励计划对象> 名单>的议案》。 务在公司官网进行了公示，公司员工可在公示期限内向监事会提出反馈意见，截至公 示期满公司监事会未收到任何组织或个人对本激励计划拟激励对象提出的异议。2 ...

Core Viewpoint - The company conducted a self-examination regarding insider trading activities related to its 2025 Restricted Stock Incentive Plan, confirming no violations occurred during the specified period [1][2][3]. Summary by Sections Insider Trading Self-Examination - The company reviewed insider trading activities of individuals aware of the 2025 Restricted Stock Incentive Plan during the six months prior to its public disclosure, from December 20, 2024, to June 20, 2025 [2]. - Two individuals classified as insider information knowers engaged in stock trading during this period, but their actions were based solely on personal market analysis, without knowledge of the incentive plan details [2][3]. Stock Buyback Activities - During the self-examination period, the company repurchased a total of 1,740,800 shares through a dedicated securities account via centralized bidding, adhering to legal disclosure requirements [3]. - The company confirmed that no insider information was utilized for trading during the stock buyback process [3]. Compliance and Conclusion - The company followed relevant laws and internal confidentiality protocols, ensuring that only a limited number of individuals participated in discussions regarding the incentive plan [3]. - The examination concluded that no insider trading or information leakage occurred related to the 2025 incentive plan, aligning with regulatory requirements [3].

Core Points - The company has announced the results of the first vesting period for the 2024 restricted stock incentive plan, with a total of 1.50% of the company's total shares being granted at a price of 3.58 yuan per share [1][2][3] - A total of 1,717,000 shares were granted, representing 4.28% of the company's total shares at the time of the announcement, with 1,597,000 shares granted in the first round [2][3] - The vesting conditions include performance targets based on net profit growth over three years, with specific thresholds set for each vesting period [4][5] Incentive Plan Details - The incentive plan was approved by the board and supervisory committee, and the first grant was made on July 1, 2024, to 167 individuals [6][7] - The vesting schedule includes three periods: 40% after 12 months, 30% after 24 months, and 30% after 36 months [3][4] - The performance assessment for the first vesting period requires a net profit of at least 17.5 million yuan for 2024, which is a growth from the 2023 net profit of 7,814.16 million yuan [4][15] Shareholder Impact - Following the vesting, the total number of shares will increase from 567,068,743 to 571,982,940, with a minor impact on earnings per share [16][17] - The funds raised from the share issuance will be used to supplement the company's working capital [16] Legal and Financial Advisory - The company has obtained necessary approvals and authorizations for the incentive plan, ensuring compliance with relevant regulations [18] - Independent financial advisors have confirmed that the vesting conditions have been met and that the plan does not harm the interests of the company or its shareholders [18]

会议材料 华峰测控2025年第二次临时股东大会 北京华峰测控技术股份有限公司 二零二五年七月 华峰测控2025年第二次临时股东大会 股东大会须知 为保障北京华峰测控技术股份有限公司（下称"公司"）全体股东的合法权 益，维护股东大会的正常秩序，保证股东大会的议事效率，确保本次股东大会如 期、顺利召开，根据《中华人民共和国公司法》《北京华峰测控技术股份有限公 司章程》《北京华峰测控技术股份有限公司股东大会议事规则》及中国证券监督 管理委员会、上海证券交易所的有关规定，特制定本须知。 一、股东大会设会务组，由公司董事会秘书负责会议的程序安排和会务工作。 二、为保证股东大会的严肃性和正常秩序，切实维护与会股东（或股东代表） 的合法权益，除出席会议的股东（或股东代表）、公司董事、监事、高级管理人 员、见证律师及董事会邀请的人员外，公司有权依法拒绝其他人员进入会场。 三、出席会议的股东（或股东代表）须在会议召开前20分钟到会议现场办理 签到手续，并请按规定出示证券账户卡、身份证或法人单位证明、授权委托书以 及参会回执等，经验证后领取会议资料，方可出席会议。 四、股东（或股东代表）依法享有发言权、咨询权和表决权等各项权益。 ...

登录新浪财经APP 搜索【信披】查看更多考评等级 长江商报消息 ●长江商报记者 黄聪 上市公司掌门人被留置调查又添一人。 7月6日晚间，新里程（002219.SZ）公告显示，公司董事长林杨林被太原市小店区监察委员会实施留置 并立案调查。 资料显示，林杨林1981年出生，2021年3月起成为新里程董事长，是一名80后掌门人。 林杨林上任后扭转了新里程持续亏损局面，但业绩也并不稳定。 2022年12月，新里程发布了2022年限制性股票激励计划（草案），2023年至2025年，公司力争营业收入 分别为35.4亿元、41.1亿元和49亿元。 2023年，新里程营业收入达39.14亿元，完成目标。但2024年，公司营业收入下降2.95%，没有完成业绩 考核目标。 长江商报记者发现，要完成2025年目标，新里程营业收入增速必须要达到约29%。 然而，2025年一季度，新里程实现营业收入7.96亿元，同比下降16.49%；净利润2565.19万元，同比下 降9.35%。公司出现业绩"双降"，全年营业收入目标难期。 2021年3月底，新里程董事会同意选举林杨林为公司第五届董事会董事长，任期至第五届董事会届满之 日止。 林杨林 ...

Core Viewpoint - The Shanghai Jingfeng Mingyuan Semiconductor Co., Ltd. has approved the 2025 Restricted Stock Incentive Plan and the list of initial grant incentive objects, ensuring compliance with relevant regulations and internal procedures [1][2]. Disclosure and Review Process - The company disclosed the 2025 Restricted Stock Incentive Plan and the list of initial grant incentive objects on the Shanghai Stock Exchange website on June 27, 2025 [2]. - The public announcement period for the incentive objects lasted from June 27, 2025, to July 6, 2025, allowing employees to provide feedback [2][3]. - No objections were received from any organization or individual regarding the proposed incentive objects by the end of the public announcement period [3]. Supervisory Board's Review Opinion - The Supervisory Board confirmed that the list of incentive objects aligns with the defined scope of the incentive plan, including directors, senior management, core technical personnel, and other personnel deemed necessary for incentives [3][4]. - The incentive objects meet the qualifications stipulated by the Company Law and Securities Law, as well as the conditions set forth in the management regulations [4][5]. - The basic information of the incentive objects is accurate, with no instances of falsehood or significant misrepresentation [4]. - The incentive objects do not include independent directors, supervisors, or shareholders holding more than 5% of the company's shares [5].

Core Points - The company has adjusted the number and exercise price of its 2024 stock option incentive plan due to the implementation of its annual profit distribution plan [9][12] - The adjusted exercise price is set at 7.80 yuan per share, down from the previous 11.13 yuan per share [11][12] - The total number of stock options granted but not yet exercised has increased from 1,418,566 to approximately 1,974,595 [11][12] Summary by Sections Incentive Plan Overview - The incentive plan targets employees, middle management, and key personnel who directly impact the company's performance and future development [1] - The total number of stock options granted under this plan is 240,000, accounting for 1.88% of the company's total share capital [2] Adjustment Details - The adjustment was made following the company's profit distribution plan, which includes a cash dividend of 2.814904 yuan per 10 shares and a capital increase of 0.3919658 shares per 10 shares [9][10] - The adjustment methods for stock options include increasing the number of options based on capital increases and adjusting the exercise price based on dividends [10][11] Performance Assessment - The performance assessment for the stock options is based on net profit growth targets, with a minimum growth rate of 300% for 2024 and 500% for 2025 [4] - The assessment will determine the percentage of options that can be exercised based on the company's performance [4][5] Legal and Compliance - The adjustments have been reviewed and approved by the company's board and supervisory committee, ensuring compliance with relevant laws and regulations [12][13] - Legal opinions confirm that the necessary approvals and authorizations for the adjustments have been fulfilled [12]

Core Viewpoint - The supervisory board of Jinhe Biotechnology Co., Ltd. has reviewed and approved the conditions for the release of restricted stock under the 2023 Restricted Stock Incentive Plan, confirming compliance with relevant laws and regulations [1][3]. Summary by Sections Section 1: Review of Incentive Objects - The company meets the conditions for implementing the stock incentive plan as per the Management Measures and relevant regulations, confirming the eligibility of the incentive objects for the second release period and the first reserved grant period [1][2]. - The incentive objects for the current plan do not fall under any disqualifying conditions as outlined in the Management Measures [2]. Section 2: Approval of Release Conditions - The supervisory board has verified that the 70 initial incentive objects and 11 reserved incentive objects meet the conditions for the release of restricted stocks, with a total of 4,326,000 shares for the initial grant and 500,000 shares for the reserved grant approved for release [3]. Section 3: Repurchase and Cancellation of Restricted Stocks - The supervisory board has determined that 43 incentive objects did not fully meet performance targets, leading to the repurchase and cancellation of their unvested restricted stocks, totaling 2,100,000 shares [3][5]. - The repurchase price adjustment and the process for cancellation have been confirmed to comply with relevant regulations, ensuring no harm to the company or shareholders [4][5].